deltatrials
Completed PHASE4 INTERVENTIONAL NCT00182104

International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures

An International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures

Sponsor: Hamilton Health Sciences Corporation

Conditions Heart Defect Triscupid Atresia
Interventions Warfarin vs ASA
Updated 5 times since 2017 Last updated: Apr 19, 2007 Started: Aug 31, 1998 Completion: Jul 31, 2005
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Heart Defect and Triscupid Atresia, this trial is completed. The trial is conducted by Hamilton Health Sciences Corporation and has accumulated 5 data snapshots since 1998. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Aug 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hamilton Health Sciences Corporation
  • Heart and Stroke Foundation of Canada
Data source: McMaster University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations